Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
The Good Bug, a gut health-focused startup founded in 2022 by Keshav Biyani and Prabhu Karthikeyan, has raised Rs 100 crore (approximately $11.8 million) in a Series B funding round. The round was led by Susquehanna Asia Venture Capital with participation from Fireside Ventures. The company develops probiotic and gut-focused health products targeting digestion, immunity, and metabolic health, and has recently introduced a probiotic-led weight loss product with effects similar to GLP-1 drugs. The funds will be used to expand research and development, marketing, distribution, and hire across various functions.
The Good Bug secures ₹100 crore in a round led by Susquehanna Asia VC with Fireside Ventures to expand R&D, marketing, distribution and hire across functions @AnjaliS92652729 #TheGoodBug #TGB #Healthcare #Fundraising #HealthTechStartup https://t.co/xeS9gWhWBJ
Susquehanna Asia VC leads gut health startup’s $11.8m series B https://t.co/rqbTdJf23q
Gut health focussed startup Good Bug raises INR 100 Cr in Series A led by Susquehanna Asia VC with participation from Fireside Ventures. Good Bug has been lately claiming to introduce probiotic led weight loss product which has GLP I drugs like effects
